Trials / Completed
CompletedNCT06403319
Otitis Media With Effusion and Type 2 Inflammation Diseases
Otitis Media With Effusion Among Patients With Type 2 Inflammation Diseases
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100,622 (actual)
- Sponsor
- Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
Otitis media with effusion (OME) is thought to be associated with comorbidities such as allergic rhinitis, gastroesophageal reflux disease, asthma, and more. Many of these comorbidities can be caused by type 2 inflammation (T2I). This study aims to characterize the risk of undergoing OME surgery. This retrospective, matched-cohort study involved the retrospective recruitment of patients from 2009 to 2020, using the Taiwan National Health Insurance Research Database (NHIRD)
Conditions
Timeline
- Start date
- 2009-01-01
- Primary completion
- 2020-12-31
- Completion
- 2020-12-31
- First posted
- 2024-05-07
- Last updated
- 2024-05-07
Source: ClinicalTrials.gov record NCT06403319. Inclusion in this directory is not an endorsement.